resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],The NCI-H727 cell line showed inhibited growth in a dose-dependent manner when treated with the antiepileptic drug valproic acid.,['Drug response'],,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"In the NCI-H727 cell line, the somatostatin analogue octreotide did not enhance the anti-proliferative effects of the mTOR inhibitor rapamycin, nor did it inhibit rapamycin-mediated feedback activation of Akt that can induce resistance.","['Drug response', 'Signaling pathway']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"Treatment of NCI-H727 cells with the PI3K inhibitor LY294002 significantly reduced tumor cell growth as well as neuroendocrine marker expression, suggesting PI3K-Akt inhibition may be a therapeutic approach for pulmonary carcinoids.","['Drug response', 'Signaling pathway', 'Biomarker expression']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"The NCI-H727 cell line showed increased proliferation, VEGF secretion, and chromogranin A secretion when treated with growth hormone-releasing hormone (GHRH), implicating GHRH as a trophic hormone for bronchial neuroendocrine tumors.","['Growth factor response', 'Secreted factors']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"The NCI-H727 cell line expresses p53 mRNA and secretes a parathyroid hormone-like protein in a calcium-stimulated, protein kinase C-dependent manner.","['Gene expression', 'Secreted factors', 'Signaling pathway']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],The growth of the NCI-H727 cell line is inhibited by EGFR monoclonal antibodies.,['Drug response'],,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"In the NCI-H727 cell line, treatment with drugs like NSC 95397, brefeldin A, bortezomib and sanguinarine induced apoptosis.","['Drug response', 'Apoptosis']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],NCI-H727 xenografts in nude mice were used to evaluate the ability of monoclonal antibodies against EGFR to inhibit lung cancer cell growth.,"['In vivo model', 'Drug response']",,,,https://www.doi.org/10.1159/000338793
d124e590-59ba-44c6-9c9f-0b0a3c96862c,NCI-H727,['Cell Line'],"In vitro studies using the NCI-H727 cell line to evaluate new potential drugs like NSC 95397, brefeldin A, bortezomib and sanguinarine for inducing apoptosis in neuroendocrine tumor cells are scarce.",['Research application'],,,,https://www.doi.org/10.1159/000338793
